Hepatitis C and hepatocellular carcinoma

No Pathway Network information available for Hepatitis C and hepatocellular carcinoma

Pathways in the Hepatitis C and hepatocellular carcinoma SuperPath

#	Name	Source	Genes
1	Hepatitis C and hepatocellular carcinoma	WikiPathways	AKT1 BCL2L1 BIRC3 BIRC5 BRCA1 CASP3 CASP7 CASP9 CCND1 CD44 CDKN1A COL4A2 CTTN CXCL8 CXCR1 E2F2 FASLG FRZB GRB2 HIF1A HNF1A IL6 IL6R JAK1 JUN LEF1 MAPK14 MAPK3 MAPK8 MIR155 MIR24-1 MIR24-2 MIR34A MIR744 MIR92A2 MMP1 MYC MYOF NFKB1 NOS2 PODXL PTGS2 PTPN11 RAC1 RRM2 SMAD3 SMAD4 SOS1 STAT3 TGFB1 TGFBR1 TP53 UCHL1 VAV2 VEGFA (see all 55) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	CD44	CD44 Molecule (IN Blood Group)	Protein Coding	1
2	CASP9	Caspase 9	Protein Coding	1
3	CASP7	Caspase 7	Protein Coding	1
4	CASP3	Caspase 3	Protein Coding	1
5	VEGFA	Vascular Endothelial Growth Factor A	Protein Coding	1
6	UCHL1	Ubiquitin C-Terminal Hydrolase L1	Protein Coding	1
7	TP53	Tumor Protein P53	Protein Coding	1
8	TGFBR1	Transforming Growth Factor Beta Receptor 1	Protein Coding	1
9	TGFB1	Transforming Growth Factor Beta 1	Protein Coding	1
10	HNF1A	HNF1 Homeobox A	Protein Coding	1
11	STAT3	Signal Transducer And Activator Of Transcription 3	Protein Coding	1
12	BRCA1	BRCA1 DNA Repair Associated	Protein Coding	1
13	SOS1	SOS Ras/Rac Guanine Nucleotide Exchange Factor 1	Protein Coding	1
14	RRM2	Ribonucleotide Reductase Regulatory Subunit M2	Protein Coding	1
15	BCL2L1	BCL2 Like 1	Protein Coding	1
16	CCND1	Cyclin D1	Protein Coding	1
17	RAC1	Rac Family Small GTPase 1	Protein Coding	1
18	PTPN11	Protein Tyrosine Phosphatase Non-Receptor Type 11	Protein Coding	1
19	PTGS2	Prostaglandin-Endoperoxide Synthase 2	Protein Coding	1
20	MAPK8	Mitogen-Activated Protein Kinase 8	Protein Coding	1
21	MAPK3	Mitogen-Activated Protein Kinase 3	Protein Coding	1
22	PODXL	Podocalyxin Like	Protein Coding	1
23	LEF1	Lymphoid Enhancer Binding Factor 1	Protein Coding	1
24	NOS2	Nitric Oxide Synthase 2	Protein Coding	1
25	NFKB1	Nuclear Factor Kappa B Subunit 1	Protein Coding	1
26	MYC	MYC Proto-Oncogene, BHLH Transcription Factor	Protein Coding	1
27	MMP1	Matrix Metallopeptidase 1	Protein Coding	1
28	SMAD4	SMAD Family Member 4	Protein Coding	1
29	SMAD3	SMAD Family Member 3	Protein Coding	1
30	MIR34A	MicroRNA 34a	RNA Gene	1
31	MIR24-2	MicroRNA 24-2	RNA Gene	1
32	MIR24-1	MicroRNA 24-1	RNA Gene	1
33	MIR155	MicroRNA 155	RNA Gene	1
34	JUN	Jun Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
35	JAK1	Janus Kinase 1	Protein Coding	1
36	CXCR1	C-X-C Motif Chemokine Receptor 1	Protein Coding	1
37	CXCL8	C-X-C Motif Chemokine Ligand 8	Protein Coding	1
38	IL6R	Interleukin 6 Receptor	Protein Coding	1
39	IL6	Interleukin 6	Protein Coding	1
40	FASLG	Fas Ligand	Protein Coding	1
41	BIRC5	Baculoviral IAP Repeat Containing 5	Protein Coding	1
42	BIRC3	Baculoviral IAP Repeat Containing 3	Protein Coding	1
43	HIF1A	Hypoxia Inducible Factor 1 Subunit Alpha	Protein Coding	1
44	FRZB	Frizzled Related Protein	Protein Coding	1
45	AKT1	AKT Serine/Threonine Kinase 1	Protein Coding	1
46	CTTN	Cortactin	Protein Coding	1
47	E2F2	E2F Transcription Factor 2	Protein Coding	1
48	MAPK14	Mitogen-Activated Protein Kinase 14	Protein Coding	1
49	COL4A2	Collagen Type IV Alpha 2 Chain	Protein Coding	1
50	CDKN1A	Cyclin Dependent Kinase Inhibitor 1A	Protein Coding	1
51	MIR744	MicroRNA 744	RNA Gene	1
52	VAV2	Vav Guanine Nucleotide Exchange Factor 2	Protein Coding	1
53	MIR92A2	MicroRNA 92a-2	RNA Gene	1
54	GRB2	Growth Factor Receptor Bound Protein 2	Protein Coding	1
55	MYOF	Myoferlin	Protein Coding	1

Disorders associated with Hepatitis C and hepatocellular carcinoma SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Breast cancer	Enrichment	AKT1, BRCA1, HNF1A, JUN, TP53	4.90
2	Colorectal cancer	Enrichment	AKT1, BRCA1, CCND1, SMAD4, TP53	4.58
3	Breast implant-associated anaplastic large cell lymphoma	Enrichment	JAK1, STAT3	4.32
4	Aortic aneurysm	Enrichment	SMAD3, TGFBR1	4.02
5	Pancreatic cancer	Enrichment	BRCA1, SMAD4, TP53	3.87
6	Lymphoma	Enrichment	PTPN11, TP53	3.80
7	Bladder cancer	Enrichment	BRCA1, CDKN1A, TP53	3.67
8	Type 1 diabetes mellitus	Enrichment	HNF1A, IL6	3.62
9	Breast adenocarcinoma	Enrichment	AKT1, TP53	3.62
10	Noonan syndrome 3	Enrichment	PTPN11, SOS1	3.48
11	Gallbladder cancer	Enrichment	SMAD4, TP53	3.48
12	Loeys-dietz syndrome	Enrichment	SMAD3, TGFBR1	3.24
13	Gastric cancer	Enrichment	BRCA1, SMAD4, TP53	3.16
14	Leukemia, chronic lymphocytic	Enrichment	CCND1, TP53	3.15
15	Ovarian cancer	Enrichment	AKT1, BRCA1, HNF1A, TP53	3.13
16	Familial thoracic aortic aneurysm and aortic dissection	Enrichment	SMAD3, SMAD4, TGFBR1	3.13
17	Hereditary breast carcinoma	Enrichment	AKT1, BRCA1, TP53	3.13
18	Pectus excavatum	Enrichment	PTPN11, TGFBR1	3.06
19	Early-onset parkinson's disease	Enrichment	PODXL, UCHL1	2.98
20	Noonan syndrome and noonan-related syndrome	Enrichment	PTPN11, SOS1	2.79
21	Rhabdomyosarcoma	Enrichment	BRCA1, TP53	2.73
22	Inherited cancer-predisposing syndrome	Enrichment	BRCA1, PTPN11, SMAD4, TP53	2.70
23	Diffuse large b-cell lymphoma	Enrichment	STAT3, TP53	2.58
24	Noonan syndrome 1	Enrichment	PTPN11, SOS1	2.41
25	Palmoplantar keratoderma, punctate type ii	Enrichment	BRCA1	2.39
26	Proteus syndrome	Enrichment	AKT1	2.39
27	Metachondromatosis	Enrichment	PTPN11	2.39
28	Hepatic adenomas, familial	Enrichment	HNF1A	2.39
29	Noonan syndrome 4	Enrichment	SOS1	2.39
30	Leopard syndrome 1	Enrichment	PTPN11	2.39
31	Multiple self-healing squamous epithelioma	Enrichment	TGFBR1	2.39
32	Ectodermal dysplasia 17 with or without limb malformations	Enrichment	LEF1	2.39
33	Bone marrow failure syndrome 5	Enrichment	TP53	2.39
34	Papilloma of choroid plexus	Enrichment	TP53	2.39
35	Basal cell carcinoma 7	Enrichment	TP53	2.39
36	Anaplastic thyroid carcinoma	Enrichment	TP53	2.39
37	T-cell large granular lymphocyte leukemia	Enrichment	STAT3	2.39
38	Infant-type hemispheric glioma	Enrichment	BRCA1	2.39
39	Angioedema, hereditary, 7	Enrichment	MYOF	2.39
40	Microvascular complications of diabetes 1	Enrichment	VEGFA	2.39
41	Interleukin 6, serum level of, quantitative trait locus	Enrichment	IL6R	2.39
42	Soluble interleukin-6 receptor, serum level of, quantitative trait locus	Enrichment	IL6R	2.39
43	Cowden syndrome 6	Enrichment	AKT1	2.39
44	Hyper-ige syndrome 5, autosomal recessive, with recurrent infections	Enrichment	IL6R	2.39
45	Type 1 diabetes mellitus 20	Enrichment	HNF1A	2.39
46	Parkinson disease 5, autosomal dominant	Enrichment	UCHL1	2.39
47	Ductal carcinoma in situ	Enrichment	TP53	2.39
48	Autoimmune disease, multisystem, infantile-onset, 1	Enrichment	STAT3	2.39
49	Thyroid gland undifferentiated carcinoma	Enrichment	TP53	2.39
50	Small-cell carcinoma of the ovary of hypercalcemic type	Enrichment	TP53	2.39
51	Heritable thoracic aortic disease	Enrichment	SMAD4	2.39
52	Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype	Enrichment	TP53	2.39
53	Stat3-related early-onset multisystem autoimmune disease	Enrichment	STAT3	2.39
54	Choroid plexus cancer	Enrichment	TP53	2.39
55	Pleomorphic xanthoastrocytoma	Enrichment	TP53	2.39
56	Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom	Enrichment	RAC1	2.39
57	Chronic lymphoproliferative disorder of natural killer cells	Enrichment	STAT3	2.39
58	Mendelian susceptibility to mycobacterial diseases due to partial jak1 deficiency	Enrichment	JAK1	2.39
59	Primary peritoneal carcinoma	Enrichment	BRCA1	2.39
60	Malignant astrocytoma	Enrichment	PTPN11	2.39
61	Rasopathy	Enrichment	PTPN11, SOS1	2.31
62	Prostate cancer	Enrichment	BRCA1, TP53	2.21
63	Lung cancer	Enrichment	BRCA1, FASLG	2.13
64	Ectrodactyly and ectodermal dysplasia without cleft lip/palate	Enrichment	LEF1	2.09
65	Burkitt lymphoma	Enrichment	MYC	2.09
66	Fibromatosis, gingival, 1	Enrichment	SOS1	2.09
67	Myhre syndrome	Enrichment	SMAD4	2.09
68	Adrenocortical carcinoma, hereditary	Enrichment	TP53	2.09
69	Camurati-engelmann disease 1	Enrichment	TGFB1	2.09
70	Cervical cancer	Enrichment	TP53	2.09
71	Pulmonic stenosis	Enrichment	SOS1	2.09
72	Loeys-dietz syndrome 2	Enrichment	TGFBR1	2.09
73	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	Enrichment	SMAD4	2.09
74	Lymphoma, hodgkin, classic	Enrichment	TP53	2.09
75	Immunodeficiency, common variable, 12, with autoimmunity	Enrichment	NFKB1	2.09
76	Loeys-dietz syndrome 3	Enrichment	SMAD3	2.09
77	Spastic paraplegia 79b, autosomal recessive	Enrichment	UCHL1	2.09
78	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1	Enrichment	COL4A2	2.09
79	Intellectual developmental disorder, autosomal dominant 48	Enrichment	RAC1	2.09
80	Fanconi anemia, complementation group s	Enrichment	BRCA1	2.09
81	Werner syndrome	Enrichment	PTPN11	2.09
82	Inflammatory bowel disease, immunodeficiency, and encephalopathy	Enrichment	TGFB1	2.09
83	Pancreatic cancer 4	Enrichment	BRCA1	2.09
84	Recessive dystrophic epidermolysis bullosa	Enrichment	MMP1	2.09
85	Hereditary spastic paraplegia 79a	Enrichment	UCHL1	2.09
86	Split hand-foot malformation	Enrichment	LEF1	2.09
87	Camurati-engelmann disease	Enrichment	TGFB1	2.09
88	Congenital fibrosarcoma	Enrichment	TP53	2.09
89	Li-fraumeni syndrome 1	Enrichment	TP53	2.09
90	Sarcoma	Enrichment	TP53	2.09
91	Autoinflammation, immune dysregulation, and eosinophilia	Enrichment	JAK1	2.09
92	Spastic paraplegia 79a, autosomal dominant, with ataxia	Enrichment	UCHL1	2.09
93	Cervix carcinoma	Enrichment	TP53	2.09
94	Hodgkin's lymphoma	Enrichment	TP53	2.09
95	Inflammatory breast carcinoma	Enrichment	BRCA1	2.09
96	Peritoneum cancer	Enrichment	BRCA1	2.09
97	Bilateral breast cancer	Enrichment	BRCA1	2.09
98	Hyperinsulinism due to hnf1a deficiency	Enrichment	HNF1A	2.09
99	Common variable immunodeficiency 12	Enrichment	NFKB1	2.09
100	Pleomorphic rhabdomyosarcoma	Enrichment	TP53	2.09
101	Hyper-ige syndrome 1, autosomal dominant, with recurrent infections	Enrichment	STAT3	1.92
102	Juvenile polyposis syndrome	Enrichment	SMAD4	1.92
103	Immunodeficiency 98 with autoinflammation, x-linked	Enrichment	FASLG	1.92
104	Nuchal bleb, familial	Enrichment	SOS1	1.92
105	Osteogenic sarcoma	Enrichment	TP53	1.92
106	Nasopharyngeal carcinoma	Enrichment	TP53	1.92
107	Brain small vessel disease 2	Enrichment	COL4A2	1.92
108	Keratoderma-ichthyosis-deafness syndrome, autosomal recessive	Enrichment	HNF1A	1.92
109	Hyper ige syndrome	Enrichment	STAT3	1.92
110	High-grade b-cell lymphoma double-hit/triple-hit	Enrichment	MYC	1.92
111	Loeys-dietz syndrome 1	Enrichment	TGFBR1	1.92
112	Atypical teratoid rhabdoid tumor	Enrichment	TP53	1.92
113	Anaplastic astrocytoma	Enrichment	TP53	1.92
114	Chromophobe renal cell carcinoma	Enrichment	HNF1A	1.92
115	Squamous cell carcinoma	Enrichment	TP53	1.92
116	Adenocarcinoma	Enrichment	TP53	1.92
117	Bone osteosarcoma	Enrichment	TP53	1.92
118	Atypical juvenile parkinsonism	Enrichment	PODXL	1.92
119	Tricuspid valve insufficiency	Enrichment	PTPN11	1.92
120	Enchondromatosis	Enrichment	HIF1A	1.92
121	Type 2 diabetes mellitus	Enrichment	HNF1A, IL6	1.90
122	Kaposi sarcoma	Enrichment	IL6	1.79
123	Brain small vessel disease 1 with or without ocular anomalies	Enrichment	COL4A2	1.79
124	Small cell cancer of the lung	Enrichment	TP53	1.79
125	Thyroid cancer, nonmedullary, 1	Enrichment	TP53	1.79
126	Polyposis syndrome, hereditary mixed, 1	Enrichment	BRCA1	1.79
127	Autoimmune lymphoproliferative syndrome	Enrichment	FASLG	1.79
128	Maturity-onset diabetes of the young, type 3	Enrichment	HNF1A	1.79
129	Cholangiocarcinoma	Enrichment	BRCA1	1.79
130	Mantle cell lymphoma	Enrichment	CCND1	1.79
131	Lung sarcomatoid carcinoma	Enrichment	TP53	1.79
132	Embryonal rhabdomyosarcoma	Enrichment	TP53	1.79
133	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	Enrichment	PTPN11	1.79
134	Noonan syndrome with multiple lentigines	Enrichment	PTPN11	1.79
135	Systemic-onset juvenile idiopathic arthritis	Enrichment	IL6	1.79
136	Clear cell papillary renal cell carcinoma	Enrichment	HNF1A	1.79
137	Gingival fibromatosis	Enrichment	SOS1	1.79
138	Hereditary angioedema with normal c1inh not related to f12 or plg variant	Enrichment	MYOF	1.79
139	Thrombocytopenia	Enrichment	PTPN11, SMAD4	1.79
140	Lymphoma, mucosa-associated lymphoid type	Enrichment	BIRC3	1.70
141	Enchondromatosis, multiple, ollier type	Enrichment	HIF1A	1.70
142	Von hippel-lindau syndrome	Enrichment	CCND1	1.70
143	Parkinson disease 2, autosomal recessive juvenile	Enrichment	PODXL	1.70
144	Rhabdomyosarcoma 2	Enrichment	TP53	1.70
145	Rheumatoid arthritis, systemic juvenile	Enrichment	IL6	1.70
146	Breast-ovarian cancer, familial 2	Enrichment	BRCA1	1.70
147	Parkin type of early-onset parkinson disease	Enrichment	PODXL	1.70
148	Acute megakaryocytic leukemia	Enrichment	TP53	1.70
149	Generalized juvenile polyposis/juvenile polyposis coli	Enrichment	SMAD4	1.70
150	Familial porencephaly	Enrichment	COL4A2	1.70
151	Hereditary breast ovarian cancer syndrome	Enrichment	BRCA1, TP53	1.68
152	Myeloma, multiple	Enrichment	CCND1, TP53	1.67
153	Li-fraumeni syndrome	Enrichment	TP53	1.62
154	Split-hand/foot malformation 1	Enrichment	LEF1	1.62
155	Inflammatory bowel disease 25, autosomal recessive	Enrichment	TGFB1	1.62
156	Hemorrhage, intracerebral	Enrichment	COL4A2	1.62
157	Patent ductus arteriosus	Enrichment	PTPN11	1.62
158	Adrenocortical carcinoma	Enrichment	TP53	1.62
159	Clear cell renal cell carcinoma	Enrichment	HNF1A	1.62
160	Il10-related early-onset inflammatory bowel disease	Enrichment	TGFB1	1.62
161	Classic ehlers-danlos syndrome	Enrichment	TGFBR1	1.62
162	Esophageal cancer	Enrichment	TP53	1.55
163	Multiple endocrine neoplasia, type i	Enrichment	CDKN1A	1.55
164	Squamous cell carcinoma, head and neck	Enrichment	TP53	1.55
165	Multiple enchondromatosis, maffucci type	Enrichment	HIF1A	1.55
166	Essential thrombocythemia	Enrichment	TP53	1.55
167	Hereditary hemorrhagic telangiectasia	Enrichment	SMAD4	1.55
168	Common variable immunodeficiency	Enrichment	NFKB1	1.55
169	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	TP53	1.55
170	Glioma susceptibility 1	Enrichment	TP53	1.50
171	Lymphoma, non-hodgkin, familial	Enrichment	TP53	1.50
172	Permanent neonatal diabetes mellitus	Enrichment	STAT3	1.50
173	Inflammatory bowel disease 1	Enrichment	IL6	1.44
174	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	Enrichment	RAC1	1.44
175	Adult hepatocellular carcinoma	Enrichment	TP53	1.44
176	Primary hyperaldosteronism	Enrichment	TP53	1.44
177	Cowden syndrome	Enrichment	AKT1	1.44
178	Familial thoracic aortic aneurysm and dissection	Enrichment	SMAD3	1.44
179	Marfan syndrome	Enrichment	TGFBR1	1.40
180	Ciliary dyskinesia, primary, 3	Enrichment	NFKB1	1.40
181	Familial colorectal cancer	Enrichment	TP53	1.40
182	Myelodysplastic syndrome	Enrichment	TP53	1.36
183	Diabetes mellitus	Enrichment	HNF1A	1.36
184	Uterine corpus cancer	Enrichment	BRCA1	1.36
185	Specific learning disability	Enrichment	PTPN11	1.36
186	Epicanthus	Enrichment	PTPN11	1.32
187	Digeorge syndrome	Enrichment	HNF1A	1.32
188	Juvenile myelomonocytic leukemia	Enrichment	PTPN11	1.32
189	Meningioma	Enrichment	AKT1	1.32
190	Lip and oral cavity carcinoma	Enrichment	TP53	1.32
191	Congenital long qt syndrome	Enrichment	PTPN11	1.32
192	Aortic valve disease 1	Enrichment	SOS1	1.29
193	Breast-ovarian cancer, familial 1	Enrichment	BRCA1	1.29
194	Acute promyelocytic leukemia	Enrichment	STAT3	1.29
195	Aortic aneurysm, familial thoracic 1	Enrichment	SMAD3	1.26
196	Lung cancer susceptibility 3	Enrichment	TP53	1.26
197	Periventricular nodular heterotopia	Enrichment	BRCA1	1.26
198	46,xy partial gonadal dysgenesis	Enrichment	SOS1	1.26
199	Renal cell carcinoma, nonpapillary	Enrichment	HNF1A	1.23
200	Gliosarcoma	Enrichment	TP53	1.20
201	Giant cell glioblastoma	Enrichment	TP53	1.18
202	Human immunodeficiency virus type 1	Enrichment	CXCR1	1.15
203	Patent foramen ovale	Enrichment	PTPN11	1.15
204	Arteriovenous malformations of the brain	Enrichment	IL6	1.13
205	Ehlers-danlos syndrome	Enrichment	SMAD3	1.13
206	Maturity-onset diabetes of the young	Enrichment	HNF1A	1.11
207	Endometrial cancer	Enrichment	BRCA1	1.09
208	Hepatoblastoma	Enrichment	TP53	1.09
209	Hepatocellular carcinoma	Enrichment	TP53	1.07
210	Diamond-blackfan anemia 1	Enrichment	TP53	1.05
211	Malaria	Enrichment	NOS2	1.05
212	Precursor t-cell acute lymphoblastic leukemia	Enrichment	MYC	1.05
213	Scoliosis	Enrichment	PTPN11	1.03
214	Hydrops fetalis, nonimmune	Enrichment	PTPN11	1.00
215	Strabismus	Enrichment	PTPN11	0.98
216	Long qt syndrome 1	Enrichment	PTPN11	0.94
217	Non-immune hydrops fetalis	Enrichment	PTPN11	0.93
218	Cystic fibrosis	Enrichment	TGFB1	0.91
219	Connective tissue disease	Enrichment	SMAD3	0.91
220	Fanconi anemia, complementation group a	Enrichment	BRCA1	0.88
221	Diamond-blackfan anemia	Enrichment	TP53	0.87
222	Cerebral palsy	Enrichment	COL4A2	0.83
223	Leukemia, acute myeloid	Enrichment	TP53	0.82
224	Hypertrophic cardiomyopathy	Enrichment	PTPN11	0.79
225	Male infertility with azoospermia or oligozoospermia due to single gene mutation	Enrichment	PTPN11	0.69
226	Autism spectrum disorder	Enrichment	PTPN11	0.44
227	Microcephaly	Enrichment	PTPN11	0.40

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Hepatitis C and hepatocellular carcinoma

Pathway Network for Hepatitis C and hepatocellular carcinoma

Member Pathways for Hepatitis C and hepatocellular carcinoma

Pathways in the Hepatitis C and hepatocellular carcinoma SuperPath

Associated Genes for Hepatitis C and hepatocellular carcinoma

Associated Disorders for Hepatitis C and hepatocellular carcinoma

Disorders associated with Hepatitis C and hepatocellular carcinoma SuperPath

STRING Interaction Network for Hepatitis C and hepatocellular carcinoma

Sources for Hepatitis C and hepatocellular carcinoma